Among these isoforms, we further characterized the functional role of ALDH1A2 in ovarian cancer progression, because it was one of the most prominently downregulated genes, with approximately 50-fold lower expression levels in ovarian cancer cells than in normal cells (Figure 1B, Table S1). This evidence concerns the gene ALDH1A2 and ovarian cancer.